BioCentury
ARTICLE | Company News

Spencer Pharmaceutical deal

December 20, 2010 8:00 AM UTC

Private equity firm Al-Dora Holdings will acquire Spencer for $245 million, or $1.10 per share, in cash (see BioCentury, Nov 22 & Dec. 13). ...